To Evaluate the Tolerability, Pharmacokinetics, and Pharmacodynamics of IMM-H014 in Patients With MASH
Clinical trial NCT07016633 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07016633
- Sponsor
- Changchun Intellicrown Pharmaceutical Co. LTD
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-10
- Primary completion
- 2027-06-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.